Supply of Globulin, Rho (D) Immune
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
This subcontract through the Department of Defense Medical Supply Chain Pharm FSA involves the supply of Globulin, Rho (D) Immune for prime contractors on Defense Logistics Agency pharmaceutical contracts. The requirement specifies 300 MCG adult doses provided in disposable IML syringes equipped with safety mechanisms. All products must maintain USP compliance and be delivered alongside current Material Safety Data Sheets. Logistical requirements mandate strict adherence to 49 CFR, ICAO, and IMDG standards for the transport of hazardous materials. Additionally, all shipments must be labeled according to MIL-STD-129 and Medical Marking Standard No. 1. The place of performance is designated as FPO 09567, with a response deadline of September 21, 2026.
General Info
Agency
NAICS
Place of Performance
FPO, AE, 09567, USASet-Aside
Documents
This scope was carved out of SPE2DP-26-T-5103.
The full solicitation package (1 document), including the RFP, is on the prime solicitation, not on this scope.
GLOBULIN, RHO (D) IMMUN
AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
